XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ 4,832,848 $ (2,632,760)
Adjustments to reconcile net income (loss) to net provided by (cash used) in operating activities:    
Change in fair value of warrants (4,585,205) (956,035)
Interest earned on cash and marketable securities held in Trust Account (3,984,085) (115,444)
Changes in operating assets and liabilities:    
Prepaid expenses 201,892 (279,666)
Income taxes payable 795,203  
Accrued offering costs and expenses 1,653,664 3,311,387
Cash held in Trust for redeemed shares (1,093,204)  
Common stock to be redeemed 1,093,204  
Due to related party 120,000 214
Net cash provided by (used in) operating activities (965,683) (672,304)
Cash Flows from Investing Activities:    
Investment held in Trust Account   (276,000,000)
Cash withdrawn for redemptions, net 253,712,545  
Cash withdrawn from Trust Account to pay franchise tax and income taxes 1,345,596  
Net cash provided by (used in) investing activities 255,058,141 (276,000,000)
Cash Flows from Financing Activities:    
Proceeds from Initial Public Offering, net of underwriters’ fees   270,480,000
Proceeds from private placement   7,270,000
Payments of offering costs   (651,036)
Proceeds from issuance of promissory note to related party 150,000 150,000
Redemption of common stock, net (253,712,545)  
Payment of promissory note to related party   (150,000)
Net cash (used in) provided by financing activities (253,562,545) 277,098,964
Net Change in Cash 529,913 426,660
Cash – Beginning 462,274 35,614
Cash – Ending 992,187 462,274
Non-Cash Investing and Financing Activities:    
Deferred underwriting commissions charged to additional paid-in capital (2,898,000) 9,660,000
Initial value of common stock subject to possible redemption   276,000,000
Remeasurement of carrying value to redemption value 2,986,368  
Deferred offering costs paid by Sponsor loan   18,773
Modification to Private Placement Warrants to qualify as liability   $ 6,000,476
Reduction of deferred underwriting fee payable $ 2,898,000